NASDAQ$DCGO

Docgo Inc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

DocGo's financial and operating results for Q1 2023 were announced.

DocGo reported its Q1 2023 results, highlighting continued operational execution and growth in the RFP channel. The company also signed agreements to expand its remote patient monitoring and chronic care management services.

  • Continued operational execution was achieved during the quarter.
  • The company experienced an increase in backlog.
  • Growth was seen in the company's RFP channel.
  • Agreements were signed to expand remote patient monitoring and chronic care management services.

Headline financials

Total Revenue

$113M

Previous: $118M-4.1%
EPS (adj)

-$0.03

Previous: $0.09-133.3%
Capital Expenditures

-$1.98M

Previous: -$602K-228.0%
Free Cash Flow

-$5.44M

Previous: $8.77M-162.0%
Net Income

-$3.47M

Previous: $9.37M-137.0%
Operating Income

-$6.9M

Previous: $10.1M-168.4%
Gross Profit

$109M

Previous: $118M-7.2%
Cash & Equivalents

$120M

Previous: $188M-36.3%
Total Assets

$408M

Previous: $325M+25.3%
Stock-Based Comp

$8.45M

No prior period

Revenue & EPS history

Docgo · Revenue · Quarterly

$113M

Q1 2023-4.1%vs Q1 2022
Beat estimate in 11 of 14 quarters(79%)
ActualEstimate

Revenue by segment

Docgo · $187M total across 2 segments · Q3 2023

  • Mobile Health Services
    $139M
  • Transportation Services
    $47.2M

Forward guidance

DocGo reiterates its 2023 Revenue Guidance of $500-$510 million and Adjusted EBITDA Guidance of $45-$50 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

+1.9%

Avg return

Earnings day

+2.0%

Avg return

5 days after

-1.6%

Avg return

30 days after

57%

12 / 21 earnings

Positive

+32.3%

Q2 2021

Best reaction

-40.4%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.3%+0.2%-2.6%
Q4 2025+17.7%+4.0%-9.7%
Q3 2025+0.0%-3.6%-15.3%
Q1 2025-40.4%-39.9%-34.3%
Q4 2024-21.2%-22.4%-32.7%
Q3 2024+9.6%+14.0%+11.8%
Q2 2024+18.2%+7.8%+18.2%
Q1 2024-13.5%-11.2%-12.6%
Q4 2023+4.1%+0.3%+3.3%
Q3 2023+1.2%-5.3%-9.3%
Q2 2023+13.9%+12.1%-15.6%
Q1 2023+5.2%+2.4%+11.3%
Q4 2022-1.5%-4.9%-4.7%
Q3 2022-7.7%-5.1%-19.8%
Q2 2022+4.1%+16.9%+11.5%
Q1 2022-0.8%-7.3%+16.7%
Q2 2021+32.3%+48.9%+36.2%
Q4 2021+13.2%+39.2%+29.7%
Q3 2021+4.0%-2.2%-15.9%
Q1 2021-0.4%-0.4%-0.1%
Q4 2020-0.8%-0.5%+0.3%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro